⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EIKN News
Eikon Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
EIKN
Eikon Therapeutics Announces the Appointment of Ma. Fatima D. Francisco to its Board of Directors
globenewswire.com
EIKN
Form 8-K
sec.gov
EIKN
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
globenewswire.com
EIKN
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
globenewswire.com
EIKN
Form 8-K
sec.gov
EIKN
Eikon Therapeutics Reports First Quarter 2026 Financial Results and Provides Clinical Updates
globenewswire.com
EIKN
Form 8-K
sec.gov
EIKN
MRNA
AMGN
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
globenewswire.com
EIKN
Eikon Therapeutics Announces Pricing of Upsized Initial Public Offering
globenewswire.com
EIKN